Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The Hedgehog signaling pathway plays an essential role in cancer progression, including in basal cell carcinoma and medulloblastoma. This process is driven by oncogenic Gli transcription factors, which are regulated by the signaling protein Smoothened (Smo). While Smo inhibitors have shown clinical utility, drug resistance can limit their effectiveness. Here, we present a synthetic and functional evaluation of benzolactam-derived TPPB, a potent Gli inhibitor that operates downstream of Smo via protein kinase C (PKC) activation. We developed a concise, stereoselective route to the benzolactam scaffold, enabling the synthesis of TPPB. testing confirmed the antitumor activity of this lead compound in a Gli-dependent basal cell carcinoma model. To identify simplified analogues, we employed a function-oriented synthesis strategy, focusing on key positions within the scaffold that enhance Gli inhibition. Our results highlight the importance of specific benzolactam-based structural motifs and suggest guidelines for designing Smo-independent Gli inhibitors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12358977 | PMC |
| http://dx.doi.org/10.1021/acsmedchemlett.5c00324 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Overcoming resistance in RET-altered cancers through rational inhibitor design and combination therapies.
Bioorg Chem
September 2025
Department of Pharmacy, Personalized Drug Research and Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China. Electronic address:
RET tyrosine kinase, a key regulator of cellular signaling, is abnormally activated due to mutations or fusions in various cancers, making it an important therapeutic target. Traditional multi-kinase inhibitors (MKIs, such as cabozantinib and vandetanib) exhibit significant side effects due to non-selective inhibition of targets like VEGFR, and also suffer from resistance associated with RET mutations (e.g.
View Article and Find Full Text PDFHedgehog signaling pathway: A research review on a new therapeutic target for rheumatoid arthritis.
Autoimmun Rev
August 2025
Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, China; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan 610075, China. Electronic address:
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by progressive joint destruction, with existing therapies limited by adverse effects and incomplete efficacy. The Hedgehog signaling pathway, abnormally activated in RA, plays a pivotal pathogenic role by promoting synovial fibroblast proliferation/invasion, amplifying inflammatory responses, inducing chondrocyte matrix degradation, and enhancing angiogenesis. This review summarizes therapeutic strategies targeting this pathway, including small-molecule inhibitors (Smo/Gli antagonists), gene therapy (CRISPR-Cas, SMO-siRNA), and emerging approaches (mesenchymal stem cells, natural products).
View Article and Find Full Text PDFBenzolactam-Based Gli Inhibitors: Synthesis and Structural Analysis.
ACS Med Chem Lett
August 2025
Department of Chemistry and Biochemistry, Loyola University Chicago, Chicago, Illinois 60660, United States.
The Hedgehog signaling pathway plays an essential role in cancer progression, including in basal cell carcinoma and medulloblastoma. This process is driven by oncogenic Gli transcription factors, which are regulated by the signaling protein Smoothened (Smo). While Smo inhibitors have shown clinical utility, drug resistance can limit their effectiveness.
View Article and Find Full Text PDFTryptamine-Functionalized Lipid Nanocarriers Co-delivering SMO/BRD4 Inhibitors for Synergistic Medulloblastoma Therapy.
Biomater Res
August 2025
School of Pharmaceutical Science, Nanjing Tech University, Nanjing 211816, China.
The management of medulloblastoma (MB) remains a significant challenge, primarily attributed to the presence of cancer stem cells and the inadequate delivery of therapeutic agents across the blood-brain barrier. GLI, as a regulator of the hedgehog signaling pathway in normal cerebellum development, also exerts pivotal functions in MB initiation, progression, and metastasis and maintains the stemness of MB stem cells. In this study, we devised a combined therapeutic approach by integrating the BRD4 inhibitor JQ1 with the SMO inhibitor saikosaponin B1 (SSB1) to inhibit MB via regulation of GLI activation.
View Article and Find Full Text PDFGLI2/Parkin-mediated mitophagy promotes pazopanib resistance in clear cell renal cell carcinoma.
Cell Signal
November 2025
Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Qingchun Road 79, Hangzhou 310003, Zhejiang, China; Cancer Center, Zhejiang University, Qingchun Road 79, Hangzhou 310003, Zhejiang, China. Electronic address:
Advanced clear cell renal cell carcinoma (ccRCC) treatment primarily involves targeted therapy and immunotherapy; however, many patients exhibit resistance to these modalities. Understanding the mechanisms underlying this resistance is essential for improved outcomes. Herein, we created a pazopanib-resistant 786-O-PR cell line, revealing an active mitophagy pathway and increased Parkin expression in the resistant cells.
View Article and Find Full Text PDF